Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Dec 28;17(1):96.
doi: 10.1186/s13000-022-01275-8.

Intraductal oncocytic papillary neoplasm arising in Peutz-Jeghers Syndrome bile duct: a unique case report

Affiliations
Case Reports

Intraductal oncocytic papillary neoplasm arising in Peutz-Jeghers Syndrome bile duct: a unique case report

Qingyue Liu et al. Diagn Pathol. .

Abstract

Background: Peutz-Jeghers syndrome (PJS) is a rare, autosomal dominant disorder caused by germline mutations of STK11/LKB1, with an increased risk of tumors at multiple sites. Intraductal oncocytic papillary neoplasm (IOPN) is a unique subtype of intraductal papillary neoplasm of the bile duct (IPNB) defined by a premalignant neoplasm with intraductal papillary or villous growth of biliary-type epithelium. IOPN has a distinct mutation profile compared with both IPNB and intraductal papillary mucinous neoplasm (IPMN).

Case presentation: We herein describe the case of a 44-year-old woman who presented as polyps in the intestinal lumen of sigmoid colon and a 3.1 × 2.1 cm mass in the left lobe of liver. Gross feature revealed a cystic papillary mass and the neoplasm had a clear boundary with the surrounding liver tissue. Histology revealed complex papillary structures, a small amount of fine fibrovascular cores and immunohistochemistry showed extensive positive for MUC5AC, MUC6, CD117. Therefore, histological and immunohistochemical examination of the liver tumor suggested the diagnosis of IOPN. Next-generation sequencing (NGS) revealed other than STK11 germline mutation, the tumor also harbors GNAS somatic mutation at codon 478 and EGFR amplification.

Conclusion: To our knowledge, this is the first report of IOPN arising in PJS. This case enlarges the spectrum of PJS related tumors and genetic rearrangements in IOPN.

Keywords: EGFR; GNAS; Intraductal oncocytic papillary neoplasm; Peutz-Jeghers syndrome; STK11.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Pelvic CT and Abdominal MRI from the case and gross features of the neoplasm. a Pelvic CT showed nodular soft tissue shadow in the intestinal lumen of sigmoid colon, surrounded by high-density contrast agent. Red arrow indicates designate polyps. b Abdominal MRI showed a round low-density mass in the left lobe of liver with a clear border. Red arrow indicates designate IOPN. c Macroscopically, the neoplasm had a clear boundary with the surrounding liver tissue. Red arrow indicates designate IOPN
Fig. 2
Fig. 2
Histological and Immunohistochemical features of the neoplasm. a The bile duct wall and surrounding liver tissue were not invaded. (Scale bar = 1000 μm). b The neoplasm shows complex papillary structures, fine fibrovascular stalks. (Scale bar = 100 μm). c The tumor cells were abundant eosinophilic granular cytoplasm, round or oval nuclei, clear nucleoli. (Scale bar = 50 μm). d-h Tumor cells were positive for MUC5AC (d), MUC6 (e), CD117 (f), HepPar-1 (g) and the Ki-67 (h) index is relatively low. (All scale bars = 100 μm). i LKB1 staining was negative in the tumor cells. (Scale bar = 100 μm)
Fig. 3
Fig. 3
Molecular profile of the IOPN described in this case. a-c Schematic illustration of STK11 (a) mutation, GNAS (b) mutation and EGFR (c) amplification. d The sequencing result showed STK11 c.924G > A (p.W308*), exon 8 in 57.39% of 1157 reads mutation. e The sequencing result showed GNAS c.1433G > A (p.R478H), exon 1 in 52.5% of 1784 reads mutation. f The sequencing result showed EGFR amplification was 3.69 folds. (Data presented as log2 fold change at the FDR < 0.05)

Similar articles

Cited by

References

    1. Sengupta S, Bose S. Peutz-Jeghers Syndrome. N Engl J Med. 2019;380:472. doi: 10.1056/NEJMicm1806623. - DOI - PubMed
    1. Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, et al. Diagnosis and management of Cancer Risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2022;162:2063–85. doi: 10.1053/j.gastro.2022.02.021. - DOI - PubMed
    1. Goh PG, Moon HS, Sung JK, Jeong HY, Song KS. [A case of Peutz-Jeghers syndrome with intraductal papillary mucinous carcinoma of pancreas] Korean J gastroenterology = Taehan Sohwagi Hakhoe chi. 2010;55:73–7. doi: 10.4166/kjg.2010.55.1.73. - DOI - PubMed
    1. Yang CY, Huang WJ, Tsai JH, Cheng A, Chen CC, Hsu HP, et al. Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct. Mod pathology: official J United States Can Acad Pathol Inc. 2019;32:1637–45. doi: 10.1038/s41379-019-0306-9. - DOI - PubMed
    1. Singhi AD, Wood LD, Parks E, Torbenson MS, Felsenstein M, Hruban RH, et al. Recurrent rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the pancreas and bile Duct. Gastroenterology. 2020;158:573–82.e2. doi: 10.1053/j.gastro.2019.10.028. - DOI - PMC - PubMed

Publication types